Skip to main content
Year archive

Cipla Ltd. — 2021 filings

All 302 regulatory filings released by Cipla Ltd. (CIPLA) in 2021, sourced directly from the official regulator.

302 Filings
2021 Period
2021 filings (302)
Filing Released Lang
Board Meeting — Financial Results
Board/Management Information
2021-12-30 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2022 ,inter alia, to consider and approve unaudited standalone and consolidated ....
Board/Management Information
2021-12-30 English
In reference to the press release titled 'Cipla receives Emergency Use Authorisation (EUA) to launch oral anti-viral drug Cipmolnu® (Molnupiravir 200 mg) in India to treat mild to moderate ....
Regulatory Filings
2021-12-28 English
Corrigendum
Regulatory Filings
2021-12-28 English
Press Release
Regulatory Filings
2021-12-28 English
Cipla receives Emergency Use Authorisation (EUA) to launch oral anti-viral drug Cipmolnu® (Molnupiravir 200 mg) in India to treat mild to moderate COVID-19 at high risk of developing severe disease
Regulatory Filings
2021-12-28 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2021-12-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-12-22 English
Press Release
Regulatory Filings
2021-12-18 English
Cipla Receives Final Approval for Lanreotide Injection.
Regulatory Filings
2021-12-18 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 17th ....
Share Issue/Capital Change
2021-12-17 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-12-17 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2021-12-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-12-17 English
Loss of Share Certificates
Regulatory Filings
2021-12-15 English
Intimation for loss of share certificates.
Regulatory Filings
2021-12-15 English
Press Release
Capital/Financing Update
2021-12-15 English
Please find enclosed press release on acquisition of stake in Clean Max Auriga Power LLP.
Capital/Financing Update
2021-12-15 English
In compliance with the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit that ....
Capital/Financing Update
2021-12-15 English
Acquisition
Capital/Financing Update
2021-12-15 English
Updates
Regulatory Filings
2021-12-14 English
This is to inform you that Inyanga Trading 386 (Pty) Limited ('Inyanga'), wholly owned subsidiary of Cipla Medpro South Africa (Pty) Limited and a wholly owned step-down subsidiary of the ....
Regulatory Filings
2021-12-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-12-13 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached schedule of Analyst / Institutional ..
Regulatory Filings
2021-12-13 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of Analyst / Institutional ....
Regulatory Filings
2021-12-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2021-12-06 English
In compliance with the requirements of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company vide intimation dated 23rd November, 2021 ....
Regulatory Filings
2021-12-02 English
Loss of Share Certificates
Regulatory Filings
2021-12-02 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of Analyst / Institutional ....
Regulatory Filings
2021-11-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2021-11-26 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of Analyst / Institutional ....
Regulatory Filings
2021-11-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-11-24 English
Loss of Share Certificates
Regulatory Filings
2021-11-23 English
Intimation for loss of share certificates.
Regulatory Filings
2021-11-23 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-11-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-11-19 English
Cipla launches Spirofy®: Strengthens its lung leadership position by facilitating early diagnosis for COPD.
Regulatory Filings
2021-11-17 English
Press Release
Regulatory Filings
2021-11-17 English
We are pleased to inform you that Cipla Limited has been added for the first time in the 'Dow Jones Sustainability Emerging Markets Index'. The press release on the same is enclosed below.
Regulatory Filings
2021-11-15 English
Press Release
Regulatory Filings
2021-11-15 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-11-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-11-15 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 13th ....
Share Issue/Capital Change
2021-11-13 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-11-13 English
Updates
Capital/Financing Update
2021-11-09 English
Update on the Definitive Agreement entered between Cipla Technologies LLC and Pulmatrix Inc. for development and commercialization of Pulmazole is provided in the enclosed letter.
Capital/Financing Update
2021-11-09 English
Acquisition
Regulatory Filings
2021-11-02 English
Please find enclosed update on intimations dated 13th November, 2018 and 8th February, 2019 on acquisition agreement entered between InvaGen Pharmaceuticals Inc. and Avenue Therapeutics Inc.
Regulatory Filings
2021-11-02 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-11-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-11-01 English
Please find enclosed copy of the transcript of the Company's Q2 FY22 earnings conference call dated 26th October, 2021. The transcript is also available on the Company's website i.e. www.cipla.com ...
Call Transcript
2021-10-31 English
Updates
Call Transcript
2021-10-31 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-10-29 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 29th ....
Share Issue/Capital Change
2021-10-29 English
ESOP/ESOS/ESPS
Capital/Financing Update
2021-10-26 English
Please find enclosed letter dated 26 October 2021
Share Issue/Capital Change
2021-10-26 English
Please find enclosed letter dated 26 October 2021
Interim / Quarterly Report H1 2022
2021-10-26 English
Copy of Newspaper Publication
Interim / Quarterly Report H1 2022
2021-10-26 English
Please find enclosed investor presentation
Investor Presentation
2021-10-26 English
Investor Presentation
Investor Presentation
2021-10-26 English
Please find press release dated 26 October 2021
Interim / Quarterly Report Q2 2022
2021-10-26 English
Press Release
Interim / Quarterly Report Q2 2022
2021-10-26 English
Please find letter dated 26 October 2021
Interim / Quarterly Report H1 2022
2021-10-26 English
Please find enclosed letter dated 26 October 2021
Interim / Quarterly Report H1 2022
2021-10-26 English
Outcome of Board Meeting
Interim / Quarterly Report H1 2022
2021-10-26 English
Financial Result Updates
Interim / Quarterly Report
2021-10-26 English
Please find enclosed intimation dated 26th October 2021
Regulatory Filings
2021-10-26 English
Withdrawal
Capital/Financing Update
2021-10-26 English
Loss of Share Certificates
Transaction in Own Shares
2021-10-05 English
In compliance with the requirements of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company vide intimation dated 22nd September, ....
Transaction in Own Shares
2021-10-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-10-04 English
Please find enclosed schedule of Earnings Conference Call to be held on 26th October 2021.
Regulatory Filings
2021-10-04 English
Press Release
Regulatory Filings
2021-10-04 English
Eli Lilly and Cipla enter into a strategic partnership in India to enhance access to Lilly's key diabetes products
Regulatory Filings
2021-10-04 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2021 ,inter alia, to consider and approve This is to inform you that meeting of ....
Regulatory Filings
2021-09-30 English
Board Meeting — Financial Results
Regulatory Filings
2021-09-30 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-09-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-09-24 English
Loss of Share Certificates
Regulatory Filings
2021-09-22 English
Intimation for loss of share certificates.
Regulatory Filings
2021-09-22 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations, 2015), we hereby notify that Cipla Limited has subscribed ....
Capital/Financing Update
2021-09-18 English
Acquisition
Capital/Financing Update
2021-09-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-09-18 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-09-18 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 15th ....
Share Issue/Capital Change
2021-09-15 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-09-15 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alps Remedies Pvt Ltd & M N Rajkumar Garments llp
Major Shareholding Notification
2021-09-14 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-09-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-09-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-09-08 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-09-08 English
Updates
Call Transcript
2021-09-01 English
Please find enclosed the transcript of the 85th Annual General Meeting of the Company held on 25th August, 2021 through video conferencing / other audio-visual means. This transcript will ....
Call Transcript
2021-09-01 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-08-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update
2021-08-30 English
Please find enclosed details of the voting results of the 85th Annual General Meeting of the Company held on Wednesday, 25th August, 2021 at 3.00 P.M. (IST) in the format as prescribed ....
Declaration of Voting Results & Voting Rights Announcements
2021-08-25 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2021-08-25 English
Shareholders meeting
AGM Information
2021-08-25 English
We hereby notify that the 85th Annual General Meeting (AGM) of the Company was held on Wednesday, 25th August 2021 at 3.00 pm through video conferencing / Other audio-visual means (OAVM). ....
AGM Information
2021-08-25 English
Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars
Capital/Financing Update
2021-08-25 English
Press Release
Capital/Financing Update
2021-08-25 English
Acquisition
Capital/Financing Update
2021-08-25 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations, 2015), we hereby notify that Cipla Limited has entered ....
Capital/Financing Update
2021-08-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-08-23 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-08-23 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-08-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-08-19 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-08-17 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 17th ....
Share Issue/Capital Change
2021-08-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-08-16 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-08-16 English
Press Release
Regulatory Filings
2021-08-12 English
Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%)
Regulatory Filings
2021-08-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-08-10 English
Please find enclosed copy of the transcript of the Company's Q1 FY22 earnings conference call dated 5th August, 2021. The transcript is also available on the Company's website i.e. www.cipla.com ....
Call Transcript
2021-08-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-08-07 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-08-07 English
In compliance with the requirements of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, vide intimation dated 29th July, 2021 we had submitted ....
Regulatory Filings
2021-08-06 English
Loss of Share Certificates
Regulatory Filings
2021-08-06 English
Please find enclosed the letter dated 5th August 2021.
Interim / Quarterly Report Q1 2022
2021-08-05 English
Copy of Newspaper Publication
Interim / Quarterly Report Q1 2022
2021-08-05 English
Press Release
Interim / Quarterly Report Q1 2022
2021-08-05 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed investor presentation dated 5th August 2021.
Investor Presentation
2021-08-05 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed Press Release dated 5th August 2021.
Interim / Quarterly Report Q1 2022
2021-08-05 English
Please find enclosed letter dated 30th June 2021.
Interim / Quarterly Report
2021-08-05 English
Investor Presentation
Investor Presentation
2021-08-05 English
Please find enclosed letter dated 5th August 2021.
Interim / Quarterly Report
2021-08-05 English
Outcome of Board Meeting
Interim / Quarterly Report
2021-08-05 English
Financial Result Updates
Regulatory Filings
2021-08-05 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of newspaper advertisements published in Business ....
AGM Information
2021-08-02 English
Copy of Newspaper Publication
AGM Information
2021-08-02 English
Shareholders meeting
AGM Information
2021-08-01 English
This refers to the Notice of Annual General Meeting of Cipla Limited 2020-21 filed with the stock exchanges on 31st July, 2021. Kindly note that inadvertently we omitted to mention in the ....
AGM Information
2021-08-01 English
Shareholders meeting
AGM Information
2021-07-31 English
This is further to our letter dated 27th July, 2021 wherein the Company had intimated of the 85th Annual General Meeting of the Company scheduled to be held on Wednesday 25th August, 2021 ....
AGM Information
2021-07-31 English
Please find enclosed Notice of 85th Annual General Meeting along with copy of Annual Report for the year ended 31st March 2021.
AGM Information
2021-07-31 English
Loss of Share Certificates
Regulatory Filings
2021-07-29 English
Intimation for loss of share certificates.
Regulatory Filings
2021-07-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Earnings Release Q1 2022
2021-07-28 English
Please find enclosed schedule of Earnings Conference Call to be held on 5th August 2021.
Call Transcript
2021-07-28 English
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and in compliance with various circulars issued by the Ministry of Corporate ....
AGM Information
2021-07-27 English
Copy of Newspaper Publication
AGM Information
2021-07-27 English
Board Meeting — Financial Results
Regulatory Filings
2021-07-26 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve This is to inform you that a meeting ....
Regulatory Filings
2021-07-26 English
Book Closure
Notice of Dividend Amount
2021-07-26 English
The Company vide letter dated 14th May, 2021 had intimated that the Board of Directors had recommended payment of dividend of Rs. 5 per equity share (face value Rs. 2 per equity share) ....
Notice of Dividend Amount
2021-07-26 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-07-17 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 17th ....
Share Issue/Capital Change
2021-07-17 English
Appointment
Board/Management Information
2021-06-30 English
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and ....
Board/Management Information
2021-06-30 English
Copy of Newspaper Publication
AGM Information
2021-06-30 English
Please find attached herewith copies of newspaper notice published in Business Standard (English) and Sakal (Marathi) on 30th June, 2021. The notice published is for those shareholders ....
AGM Information
2021-06-30 English
Updates
Regulatory Filings
2021-06-29 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit that in response to media queries on vaccine import, the Company ....
Regulatory Filings
2021-06-29 English
Press Release
Regulatory Filings
2021-06-29 English
Cipla, Dr. Reddy's, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19
Regulatory Filings
2021-06-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-06-26 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Investor Presentation
2021-06-26 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-06-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-06-23 English
Press Release
Regulatory Filings
2021-06-23 English
Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.'s Brovana®
Capital/Financing Update
2021-06-23 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-06-16 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 16th ....
Share Issue/Capital Change
2021-06-16 English
Press Release
Regulatory Filings
2021-06-15 English
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
Regulatory Filings
2021-06-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-06-11 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-06-11 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated ....
Regulatory Filings
2021-06-08 English
Related Party Transactions
Regulatory Filings
2021-06-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-06-07 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-06-07 English
Pursuant to the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circulars No. CIR/CFD/CMD1/27/2019 dated February 8, 2019 and ....
Regulatory Filings
2021-06-01 English
Updates
Regulatory Filings
2021-05-31 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit that in response to media queries on vaccine distribution, Cipla ....
Regulatory Filings
2021-05-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-05-31 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-05-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-05-26 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-05-26 English
Press Release
Regulatory Filings
2021-05-24 English
Roche's Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India
Regulatory Filings
2021-05-24 English
Press Release
Regulatory Filings
2021-05-20 English
Press Release - Cipla launches 'ViraGen' a polymerase chain reaction (Covid-19 RT-PCR) test.
Regulatory Filings
2021-05-20 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-05-19 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 19th ....
Share Issue/Capital Change
2021-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-05-18 English
Please find enclosed signed version of the transcript of Q4 FY21 earnings conference call of the Company dated 14 May 2021. Inadvertently the Company uploaded unsigned version of the transcript ....
Call Transcript
2021-05-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-05-18 English
Please find enclosed copy of the transcript of the Company's Q4 FY21 earnings conference call dated 14th May, 2021. The transcript is also available on the Company's website i.e. www.cipla.com ....
Call Transcript
2021-05-18 English
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Audit Committee, ....
Audit Report / Information FY 2021
2021-05-14 English
Change in Auditors
Audit Report / Information FY 2021
2021-05-14 English
This is to inform you that the Company has made grants in terms of the Employee Stock Option Scheme 2013-A ('ESOS 2013-A') and the Cipla Employee Stock Appreciation Rights Scheme 2021 ('ESAR ....
Capital/Financing Update
2021-05-14 English
ESOP/ESOS/ESPS
Capital/Financing Update
2021-05-14 English
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and ....
Board/Management Information
2021-05-14 English
Appointment
Board/Management Information
2021-05-14 English
Dividend
Regulatory Filings
2021-05-14 English
Please find enclosed the outcome of Board Meeting held on 14th May 2021.
Regulatory Filings
2021-05-14 English
Outcome of Board Meeting
Regulatory Filings
2021-05-14 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed extract of consolidated ....
Interim / Quarterly Report FY 2021
2021-05-14 English
Copy of Newspaper Publication
Interim / Quarterly Report FY 2021
2021-05-14 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed investor presentation dated 14th May, 2021.
Investor Presentation
2021-05-14 English
Investor Presentation
Investor Presentation
2021-05-14 English
Press Release
Earnings Release FY 2021
2021-05-14 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Press Release dated 14th May, 2021.
Earnings Release FY 2021
2021-05-14 English
Declaration for audit reports with unmodified opinion(s)
Regulatory Filings
2021-05-14 English
Cipla Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2021, inter alia, has recommended payment of dividend of Rs. 5 per equity share ....
Annual Report FY 2021
2021-05-14 English
Please find enclosed letter dated 14th May 2021
Annual Report FY 2021
2021-05-14 English
Financial Result Updates
Annual Report
2021-05-14 English
Press Release
Capital/Financing Update
2021-05-10 English
Press release - Cipla enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India.
Regulatory Filings
2021-05-10 English
Press Release - Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19.
Regulatory Filings
2021-05-05 English
Press Release
Regulatory Filings
2021-05-05 English
Acquisition
Regulatory Filings
2021-05-03 English
This is to notify that GoApptiv Private Limited ('GoApptiv'), an associate company of Cipla Limited has incorporated a wholly-owned subsidiary company namely Iconphygital Private Limited ....
Regulatory Filings
2021-05-03 English
Acquisition
Regulatory Filings
2021-04-30 English
The Company in its intimation to the stock exchanges dated 31st March, 2021 reported subscription of up to 20% partnership interest in ABCD Technologies LLP (to be renamed IndoHealth Services ....
Regulatory Filings
2021-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2021-04-30 English
Please find enclosed schedule of Earnings Conference Call to be held on 14th May 2021.
Regulatory Filings
2021-04-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-04-28 English
Press Release - Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment
Capital/Financing Update
2021-04-28 English
Press Release
Capital/Financing Update
2021-04-28 English
Please find enclosed Certificate from a Practicing Company Secretary in compliance with Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2021-04-27 English
Updates
Declaration of Voting Results & Voting Rights Announcements
2021-04-23 English
We are enclosing certified copy of the minutes of resolutions passed through postal ballot by way of remote evoting process on 25th March, 2021. The results of postal ballot were announced ....
Declaration of Voting Results & Voting Rights Announcements
2021-04-23 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-04-21 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 21st ....
Share Issue/Capital Change
2021-04-21 English
Copy of Newspaper Publication
Regulatory Filings
2021-04-21 English
Please find enclosed notice of the Board Meeting published in newspapers viz. Business Standard and Sakal on 21st April, 2021
Regulatory Filings
2021-04-21 English
We are enclosing herewith Compliance Certificate, duly signed by the Compliance Officer of the Company and the Registrar and Share Transfer Agent, KFin Technologies Private Limited (formerly ....
Regulatory Filings
2021-04-20 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2021 ,inter alia, to consider and approve the audited standalone and consolidated ....
Regulatory Filings
2021-04-20 English
Board Meeting — Financial Results/Dividend
Board/Management Information
2021-04-20 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-19 English
Acquisition
M&A Activity
2021-04-01 English
We would like to inform you that DigiHealth Technologies LLP, the wholly owned entity of our Indian investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), ....
M&A Activity
2021-04-01 English
Acquisition
Capital/Financing Update
2021-03-31 English
We would like to inform you that our investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has through its wholly-owned entity DigiHealth Technologies LLP, ....
Capital/Financing Update
2021-03-31 English
Acquisition
Capital/Financing Update
2021-03-31 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that Cipla Limited has entered into an agreement to become a ....
Capital/Financing Update
2021-03-31 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2021-03-26 English
This is further to our letter dated 23rd February, 2021 enclosing therewith the Postal Ballot Notice. Please find enclosed details of voting results pursuant to Regulation 44(3) ....
Declaration of Voting Results & Voting Rights Announcements
2021-03-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-03-24 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-03-24 English
Updates
Board/Management Information
2021-03-23 English
In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and ....
Board/Management Information
2021-03-23 English
Press Release
Regulatory Filings
2021-03-23 English
Press Release - Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Regulatory Filings
2021-03-23 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-03-22 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Operations and Administrative Committee of the Company on 22nd ....
Share Issue/Capital Change
2021-03-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2021-03-19 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-03-19 English
Press Release
Regulatory Filings
2021-03-18 English
Press Release - Cipla pledges support to 'Terra Carta', for a sustainable future
Regulatory Filings
2021-03-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2021-03-12 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-03-12 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-03-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-03-08 English
Updates
Regulatory Filings
2021-03-06 English
This is to inform you that Cipla (UK) Limited, wholly owned subsidiary of Cipla (EU) Limited and a wholly owned step down subsidiary of the Company, has been voluntarily liquidated with ....
Regulatory Filings
2021-03-06 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-03-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-03-02 English
Press Release
Regulatory Filings
2021-03-02 English
Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand
Regulatory Filings
2021-03-02 English
Press Release - Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg)
Regulatory Filings
2021-03-02 English
Press Release
Regulatory Filings
2021-03-02 English
Pursuant to Regulation 47 read with Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we are enclosing herewith copies of newspaper advertisement ....
Proxy Solicitation & Information Statement
2021-02-24 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement
2021-02-24 English
Further to our letter dated 29th January, 2021, and pursuant to Regulation 30, 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we here by enclose Notice ....
Proxy Solicitation & Information Statement
2021-02-23 English
Shareholders meeting
Proxy Solicitation & Information Statement
2021-02-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-02-22 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-02-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-02-16 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Regulatory Filings
2021-02-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-02-08 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Investor Presentation
2021-02-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-02-02 English
Please find enclosed copy of the transcript of the Company's Q3 FY21 earnings conference call dated 29th January, 2021. The transcript is also available on the Company's website i.e. www.cipla.com ...
Call Transcript
2021-02-02 English
Outcome of Board Meeting
Board/Management Information
2021-01-29 English
Outcome of Board Meeting attached.
Regulatory Filings
2021-01-29 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed extract of consolidated ....
Interim / Quarterly Report 9M 2021
2021-01-29 English
Copy of Newspaper Publication
Interim / Quarterly Report 9M 2021
2021-01-29 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed investor presentation dated 29th January, 2021
Investor Presentation
2021-01-29 English
Investor Presentation
Investor Presentation
2021-01-29 English
Press Release
Interim / Quarterly Report Q3 2021
2021-01-29 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Press Release dated 29th ....
Interim / Quarterly Report Q3 2021
2021-01-29 English
Pursuant to Regulation 30 of the Listing Regulations we hereby inform that based on the recommendation of the Audit Committee and the Committee of Independent Directors, the Board of Directors ....
Capital/Financing Update
2021-01-29 English
Scheme of Arrangement
Capital/Financing Update
2021-01-29 English
Financial Result Updates
Regulatory Filings
2021-01-29 English
Please find enclosed letter dated 29th January 2021.
Interim / Quarterly Report 9M 2021
2021-01-29 English
Cipla champions its commitment to carbon neutrality with its 30 MW solar plant in Maharashtra.
Environmental & Social Information
2021-01-27 English
Press Release
Environmental & Social Information
2021-01-27 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-01-20 English
The Operations and Administrative Committee of the Company on 20th January, 2021 has allotted 5,217 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option ....
Share Issue/Capital Change
2021-01-20 English
We are enclosing herewith copy of the transcript of the Company's 39th Annual J.P. Morgan Healthcare Conference. The transcript is also available on the Company's website i.e. www.cipla.com ....
Investor Presentation
2021-01-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-01-18 English
Please find enclosed schedule of Earnings Conference Call to be held on 29th January 2021.
Regulatory Filings
2021-01-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-01-13 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the schedule of Analyst / Institutional ....
Investor Presentation
2021-01-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2021-01-12 English
Copy of Newspaper Publication
Regulatory Filings
2021-01-07 English
Please find enclosed notice of the Board Meeting published in newspapers viz. Business Standard and Sakal on 7th January, 2021
Regulatory Filings
2021-01-07 English
Board Meeting — Financial Results
Regulatory Filings
2021-01-06 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2021 ,inter alia, to consider and approve unaudited standalone and consolidated ....
Regulatory Filings
2021-01-06 English